Financing and other transactions

Financing Advisory

Colosseum Dental Group (2025)

  • Acted as sole financial adviser to Colosseum Dental Group and its shareholder, Jacobs Holding, in relation to the refinancing of CDG’s existing private credit financing through a debut €1,050m TLB issuance, the refinancing of its RCF to €175m, and the concurrent amend & extend of its outstanding €136m HoldCo PIK facility
  • Ran rigorous RfP process to assess bookrunner views on credit ratings, credit and cashflow profile, particularly given performance of direct comparables in the market
  • Formulated broad physical and non-physical bookrunner syndicate with innovative fee structure in order to (i) raise a substantial €175m RCF to support the buy and build strategy, (ii) ensure the business had strong suite of distributing banks and banks with tier 1 ratings capabilities, and (iii) facilitate the Amend & Extend of the HoldCo PIK
  • Negotiated TLB covenant package on behalf of CDG to ensure sufficient flexibility to execute its buy and build strategy and refinance PIK over time
  • Advised on concurrent HoldCo PIK amend & extend to ensure TLB documentation flexibility was preserved while optimising economics including call protection

Wren House & Voyage Care (2025)

  • Debt and hedging advice to Wren House and Voyage Care on its £425m refinancing
  • Rothschild & Co advised on the sale of Voyage Care to Wren House in December 2022 and has maintained a close relationship with the Company
  • The transaction exemplifies Rothschild & Co's multi-disciplinary offering, with Debt Advisory, Healthcare, and Infrastructure personnel involved
  • Rothschild & Co advised on all aspects of the financing, including drafting all marketing materials, model, and holistic diligence suite; managing diligence and lender education across more than 100 lender counterparties; structuring and negotiation of all aspects of the financing
  • Advised on all aspects of the hedging process, including assessing strategic hedging alternatives, drafting and co-ordinating the hedging RfQ; advising on allocation strategy and appointment of hedge execution bank

emeis (2025)

  • Sole financial adviser to emeis (formerly Orpea) on its €3.15bn refinancing
  • emeis appointed Rothschild & Co to assess options with regards to its post restructuring debt structure
  • Rothschild & Co advised emeis on refinancing options available and provided assistance in the negotiation of key financial terms
  • The transaction highlights the strong relationship between emeis and Rothschild & Co, building on Rothschild & Co’s prior involvement in the €1.7bn emergency financing and €1.5bn optional syndicated facility raised in H1 2022, the €9.7bn debt restructuring completed over 2023–2024, and the €761m preferred equity instrument announced in September 2025

Gruppo San Donato (2025)

  • Debt advice to Gruppo San Donato on its €1.5bn refinancing including a €800m inaugural SSNs issuance
  • The Transaction aimed at: (i) refinancing the Group’s existing financial indebtedness for ~€800m (ii) raising €250m resources to fund the exercise of the put option related to the residual minority stake in the Polish healthcare group AHP (majority stake acquired by GSD in 2023), (iii) funding ~€300m one-off distribution to the holding company to refinance its existing debt and also distribute dividends to shareholders and, (iv) provide GSD with a €150m RCF for general corporate purposes
  • Rothschild & Co provided comprehensive independent advice to GSD on all aspects of the Transaction, including the definition of the most appropriate financing strategy; assisted the management team in the preparation of a detailed business plan, the development of a corresponding financing case; led commercial negotiations; advise on waivers and consent processes; bookrunner syndicate management; discussion with rating agencies to optimize rating outcome and review of key bond-related documentation
  • The Transaction further reaffirms Rothschild & Co’s trusted long-term relationship with GSD over the years, and further strengthens our market-leading position in debt advisory and our leadership as independent advisor to Italian high yield bond issuers

Oral Care (2025)

  • Debt advice to Oral Care on its SEK 2.1bn refinancing
  • Oral Care appointed Rothschild & Co in September 2024 to explore potential refinancing options for the existing bank facilities, following a strong track-record of financial performance via acquisition-led growth (>30 acquisitions in the last three years)
  • Rothschild & Co advised on all aspects of the transaction, including running parallel terms grid negotiations with three funds; scoping and reviewing of financial due diligence including advice on like-for-like analysis for historical M&A; drafting marketing materials including assisting with building the business plan, successfully tailoring the credit story; negotiating and securing a highly attractive financing package with front-of-market terms compared to Oral Care’s previous restrictive bank club structure, allowing for greater flexibility to execute its buy-and-build strategy

Exemplar (2024)

  • Acted as sole financial adviser to Ares Private Equity (“Ares”) and Exemplar Health Care Group Limited (“Exemplar”) on Exemplar’s new £490m refinancing, comprising a £450m unitranche (of which £150m structured as committed capex line) and £40m Super Senior RCF
  • Strategic advice on greenfield expansion plan and related operating assumptions to optimise business profile, including providing proof of ability to scale rapidly ahead of exit
  • Tactically structured process focused on incumbents, new lenders, and their co-investors to maximise liquidity pool, and thereby competitive tension, allowing for selection of more favourable financing structure
  • Font-of-market terms for challenging sector, including discounted fees, 150bps margin reduction, debt incurrence 1x above opening leverage for life, bespoke RR-EBITDA formulation, highly permissive S&LB flexibility and portability (including capex line availability for recap at portability)